Premier Research is a business services company based in the United States, specializing in research and development within the biotech and pharmaceuticals sectors. Founded in 1987, the company has grown to employ between 1,001 and 5,000 individuals and reported revenue of approximately $731 million. Premier Research focuses on providing clinical development services, particularly for companies engaged in developing investigative medicinal products. One of its documented projects involved assisting in the screening and enrollment for a Phase 2 clinical study targeting advanced, recurrent, non-resectable cervical cancer. This study highlighted the challenges posed by the COVID-19 pandemic, including delays in regulatory review and staffing shortages at multiple sites, which impacted the study's timeline and patient enrollment rates. The company emphasized the importance of team coordination and site engagement to navigate these difficulties and enhance enrollment outcomes. Premier Research's expertise lies in managing complex clinical trials, particularly in areas of high unmet clinical need within the oncology space.